Financhill
Sell
19

INBS Quote, Financials, Valuation and Earnings

Last price:
$4.48
Seasonality move :
-50.57%
Day range:
$4.03 - $4.50
52-week range:
$3.70 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.38x
P/B ratio:
0.35x
Volume:
42.3K
Avg. volume:
146.5K
1-year change:
-78.48%
Market cap:
$3.9M
Revenue:
$3.1M
EPS (TTM):
-$10.97

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
INBS
Intelligent Bio Solutions, Inc.
$1.4M -- 160.36% -- --
LAB
Standard BioTools, Inc.
$18.5M -$0.03 -56.37% -70.93% $1.55
LUDG
Ludwig Enterprises, Inc.
-- -- -- -- --
MHTX
Manhattan Scientifics, Inc.
-- -- -- -- --
OPGN
-- -- -- -- --
USAQ
QHSLab, Inc.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
INBS
Intelligent Bio Solutions, Inc.
$4.10 -- $3.9M -- $0.00 0% 2.38x
LAB
Standard BioTools, Inc.
$1.04 $1.55 $399.9M -- $0.00 0% 3.75x
LUDG
Ludwig Enterprises, Inc.
$0.0221 -- $3.6M -- $0.00 0% 37,130.15x
MHTX
Manhattan Scientifics, Inc.
$0.0000 -- $600 -- $0.00 0% --
OPGN
$24.7500 -- $249.3M 61.89x $0.00 0% 27.78x
USAQ
QHSLab, Inc.
$0.7349 -- $8.3M -- $0.00 0% 3.70x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
INBS
Intelligent Bio Solutions, Inc.
14.79% 3.516 21.53% 0.23x
LAB
Standard BioTools, Inc.
6.77% 0.460 6.26% 1.86x
LUDG
Ludwig Enterprises, Inc.
-144.65% 0.332 24.05% 0.00x
MHTX
Manhattan Scientifics, Inc.
-- 80.588 -- --
OPGN
16.9% -39,423.208 205167.16% 5.70x
USAQ
QHSLab, Inc.
162.97% -1.352 73.75% 0.17x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
INBS
Intelligent Bio Solutions, Inc.
$177.8K -$2.7M -179.5% -215.68% -298.99% -$1.7M
LAB
Standard BioTools, Inc.
$10.2M -$21.9M -13.22% -14.14% -92.14% -$1.7M
LUDG
Ludwig Enterprises, Inc.
-- -$371.4K -- -- -419868.12% -$139.1K
MHTX
Manhattan Scientifics, Inc.
-- -$160K -- -- -- -$17K
OPGN
-$48.1K -$702.2K 70.06% 89.47% -5625.96% -$333.3K
USAQ
QHSLab, Inc.
$475.6K $96.3K -35.74% -- 13.05% $2.6K

Intelligent Bio Solutions, Inc. vs. Competitors

  • Which has Higher Returns INBS or LAB?

    Standard BioTools, Inc. has a net margin of -299.58% compared to Intelligent Bio Solutions, Inc.'s net margin of 58.42%. Intelligent Bio Solutions, Inc.'s return on equity of -215.68% beat Standard BioTools, Inc.'s return on equity of -14.14%.

    Company Gross Margin Earnings Per Share Invested Capital
    INBS
    Intelligent Bio Solutions, Inc.
    19.83% -$2.82 $12.8M
    LAB
    Standard BioTools, Inc.
    43.03% $0.05 $455.1M
  • What do Analysts Say About INBS or LAB?

    Intelligent Bio Solutions, Inc. has a consensus price target of --, signalling upside risk potential of 2826.83%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 49.04%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Standard BioTools, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INBS
    Intelligent Bio Solutions, Inc.
    0 0 0
    LAB
    Standard BioTools, Inc.
    1 2 0
  • Is INBS or LAB More Risky?

    Intelligent Bio Solutions, Inc. has a beta of 4.581, which suggesting that the stock is 358.122% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.359, suggesting its more volatile than the S&P 500 by 35.922%.

  • Which is a Better Dividend Stock INBS or LAB?

    Intelligent Bio Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INBS or LAB?

    Intelligent Bio Solutions, Inc. quarterly revenues are $896.8K, which are smaller than Standard BioTools, Inc. quarterly revenues of $23.8M. Intelligent Bio Solutions, Inc.'s net income of -$2.7M is lower than Standard BioTools, Inc.'s net income of $13.9M. Notably, Intelligent Bio Solutions, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions, Inc. is 2.38x versus 3.75x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INBS
    Intelligent Bio Solutions, Inc.
    2.38x -- $896.8K -$2.7M
    LAB
    Standard BioTools, Inc.
    3.75x -- $23.8M $13.9M
  • Which has Higher Returns INBS or LUDG?

    Ludwig Enterprises, Inc. has a net margin of -299.58% compared to Intelligent Bio Solutions, Inc.'s net margin of -427991.3%. Intelligent Bio Solutions, Inc.'s return on equity of -215.68% beat Ludwig Enterprises, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    INBS
    Intelligent Bio Solutions, Inc.
    19.83% -$2.82 $12.8M
    LUDG
    Ludwig Enterprises, Inc.
    -- -- -$1.4M
  • What do Analysts Say About INBS or LUDG?

    Intelligent Bio Solutions, Inc. has a consensus price target of --, signalling upside risk potential of 2826.83%. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Ludwig Enterprises, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Ludwig Enterprises, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INBS
    Intelligent Bio Solutions, Inc.
    0 0 0
    LUDG
    Ludwig Enterprises, Inc.
    0 0 0
  • Is INBS or LUDG More Risky?

    Intelligent Bio Solutions, Inc. has a beta of 4.581, which suggesting that the stock is 358.122% more volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.693, suggesting its more volatile than the S&P 500 by 169.348%.

  • Which is a Better Dividend Stock INBS or LUDG?

    Intelligent Bio Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions, Inc. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INBS or LUDG?

    Intelligent Bio Solutions, Inc. quarterly revenues are $896.8K, which are larger than Ludwig Enterprises, Inc. quarterly revenues of --. Intelligent Bio Solutions, Inc.'s net income of -$2.7M is lower than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, Intelligent Bio Solutions, Inc.'s price-to-earnings ratio is -- while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions, Inc. is 2.38x versus 37,130.15x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INBS
    Intelligent Bio Solutions, Inc.
    2.38x -- $896.8K -$2.7M
    LUDG
    Ludwig Enterprises, Inc.
    37,130.15x -- -- $31.3K
  • Which has Higher Returns INBS or MHTX?

    Manhattan Scientifics, Inc. has a net margin of -299.58% compared to Intelligent Bio Solutions, Inc.'s net margin of --. Intelligent Bio Solutions, Inc.'s return on equity of -215.68% beat Manhattan Scientifics, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    INBS
    Intelligent Bio Solutions, Inc.
    19.83% -$2.82 $12.8M
    MHTX
    Manhattan Scientifics, Inc.
    -- -$0.00 --
  • What do Analysts Say About INBS or MHTX?

    Intelligent Bio Solutions, Inc. has a consensus price target of --, signalling upside risk potential of 2826.83%. On the other hand Manhattan Scientifics, Inc. has an analysts' consensus of -- which suggests that it could grow by 24999900%. Given that Manhattan Scientifics, Inc. has higher upside potential than Intelligent Bio Solutions, Inc., analysts believe Manhattan Scientifics, Inc. is more attractive than Intelligent Bio Solutions, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INBS
    Intelligent Bio Solutions, Inc.
    0 0 0
    MHTX
    Manhattan Scientifics, Inc.
    0 0 0
  • Is INBS or MHTX More Risky?

    Intelligent Bio Solutions, Inc. has a beta of 4.581, which suggesting that the stock is 358.122% more volatile than S&P 500. In comparison Manhattan Scientifics, Inc. has a beta of 9.435, suggesting its more volatile than the S&P 500 by 843.464%.

  • Which is a Better Dividend Stock INBS or MHTX?

    Intelligent Bio Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Manhattan Scientifics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions, Inc. pays -- of its earnings as a dividend. Manhattan Scientifics, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INBS or MHTX?

    Intelligent Bio Solutions, Inc. quarterly revenues are $896.8K, which are larger than Manhattan Scientifics, Inc. quarterly revenues of --. Intelligent Bio Solutions, Inc.'s net income of -$2.7M is lower than Manhattan Scientifics, Inc.'s net income of -$158K. Notably, Intelligent Bio Solutions, Inc.'s price-to-earnings ratio is -- while Manhattan Scientifics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions, Inc. is 2.38x versus -- for Manhattan Scientifics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INBS
    Intelligent Bio Solutions, Inc.
    2.38x -- $896.8K -$2.7M
    MHTX
    Manhattan Scientifics, Inc.
    -- -- -- -$158K
  • Which has Higher Returns INBS or OPGN?

    has a net margin of -299.58% compared to Intelligent Bio Solutions, Inc.'s net margin of -5629.82%. Intelligent Bio Solutions, Inc.'s return on equity of -215.68% beat 's return on equity of 89.47%.

    Company Gross Margin Earnings Per Share Invested Capital
    INBS
    Intelligent Bio Solutions, Inc.
    19.83% -$2.82 $12.8M
    OPGN
    55.51% -$0.06 $12.2M
  • What do Analysts Say About INBS or OPGN?

    Intelligent Bio Solutions, Inc. has a consensus price target of --, signalling upside risk potential of 2826.83%. On the other hand has an analysts' consensus of -- which suggests that it could grow by 21.21%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than , analysts believe Intelligent Bio Solutions, Inc. is more attractive than .

    Company Buy Ratings Hold Ratings Sell Ratings
    INBS
    Intelligent Bio Solutions, Inc.
    0 0 0
    OPGN
    0 0 0
  • Is INBS or OPGN More Risky?

    Intelligent Bio Solutions, Inc. has a beta of 4.581, which suggesting that the stock is 358.122% more volatile than S&P 500. In comparison has a beta of -3,221.492, suggesting its less volatile than the S&P 500 by 322249.211%.

  • Which is a Better Dividend Stock INBS or OPGN?

    Intelligent Bio Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions, Inc. pays -- of its earnings as a dividend. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INBS or OPGN?

    Intelligent Bio Solutions, Inc. quarterly revenues are $896.8K, which are larger than quarterly revenues of --. Intelligent Bio Solutions, Inc.'s net income of -$2.7M is lower than 's net income of -$608.7K. Notably, Intelligent Bio Solutions, Inc.'s price-to-earnings ratio is -- while 's PE ratio is 61.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions, Inc. is 2.38x versus 27.78x for . Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INBS
    Intelligent Bio Solutions, Inc.
    2.38x -- $896.8K -$2.7M
    OPGN
    27.78x 61.89x -- -$608.7K
  • Which has Higher Returns INBS or USAQ?

    QHSLab, Inc. has a net margin of -299.58% compared to Intelligent Bio Solutions, Inc.'s net margin of 4.53%. Intelligent Bio Solutions, Inc.'s return on equity of -215.68% beat QHSLab, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    INBS
    Intelligent Bio Solutions, Inc.
    19.83% -$2.82 $12.8M
    USAQ
    QHSLab, Inc.
    64.52% $0.00 $970.2K
  • What do Analysts Say About INBS or USAQ?

    Intelligent Bio Solutions, Inc. has a consensus price target of --, signalling upside risk potential of 2826.83%. On the other hand QHSLab, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Intelligent Bio Solutions, Inc. has higher upside potential than QHSLab, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than QHSLab, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INBS
    Intelligent Bio Solutions, Inc.
    0 0 0
    USAQ
    QHSLab, Inc.
    0 0 0
  • Is INBS or USAQ More Risky?

    Intelligent Bio Solutions, Inc. has a beta of 4.581, which suggesting that the stock is 358.122% more volatile than S&P 500. In comparison QHSLab, Inc. has a beta of 0.516, suggesting its less volatile than the S&P 500 by 48.351%.

  • Which is a Better Dividend Stock INBS or USAQ?

    Intelligent Bio Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QHSLab, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions, Inc. pays -- of its earnings as a dividend. QHSLab, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INBS or USAQ?

    Intelligent Bio Solutions, Inc. quarterly revenues are $896.8K, which are larger than QHSLab, Inc. quarterly revenues of $737.1K. Intelligent Bio Solutions, Inc.'s net income of -$2.7M is lower than QHSLab, Inc.'s net income of $33.4K. Notably, Intelligent Bio Solutions, Inc.'s price-to-earnings ratio is -- while QHSLab, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions, Inc. is 2.38x versus 3.70x for QHSLab, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INBS
    Intelligent Bio Solutions, Inc.
    2.38x -- $896.8K -$2.7M
    USAQ
    QHSLab, Inc.
    3.70x -- $737.1K $33.4K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
46
ZD alert for Mar 5

Ziff Davis, Inc. [ZD] is up 3.64% over the past day.

Sell
40
PSIX alert for Mar 5

Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.

Sell
49
TREE alert for Mar 5

LendingTree, Inc. [TREE] is up 1.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock